NCT05306704 (HDVDS-HIVT) is a Phase 3 clinical trial of 25-Hydroxyvitamin D in HIV-1-infection, sponsored by University of the Punjab.

Who is sponsoring NCT05306704?

NCT05306704 is sponsored by University of the Punjab.

What drugs are being tested in NCT05306704?

Interventions in NCT05306704: placebo Oil, 25-Hydroxyvitamin D.

What condition does NCT05306704 study?

NCT05306704 studies HIV-1-infection, Hypovitaminosis D.

Is NCT05306704 still recruiting?

NCT05306704 is currently completed. Last updated 11 April 2022.

Last reviewed 2022-04-11 · How we verify

NCT05306704: HDVDS-HIVT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial

Completed Phase 3 Last updated 11 April 2022

What this trial tests

Phase 3 trial testing placebo Oil in HIV-1-infection in 95 participants. Completed in 31 January 2022.

Timeline

15 February 2019

Primary endpoint
31 January 2022

31 January 2022

Quick facts

Lead sponsor	University of the Punjab
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	supportive care
Enrollment	95
Start date	15 February 2019
Primary completion	31 January 2022
Estimated completion	31 January 2022
Sites	2 locations across Pakistan

Drugs / interventions tested

placebo Oil
25-Hydroxyvitamin D — full drug profile →

Conditions studied

HIV-1-infection — all drugs for HIV-1-infection →
Hypovitaminosis D — all drugs for Hypovitaminosis D →

Sponsor

University of the Punjab

Who can join

19 and older, any sex, with HIV-1-infection or Hypovitaminosis D. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High-Dose Vitamin D3 in the Treatment of Human Immune Deficiency Virus Patients, A Double-Blind Randomized Control Trial Human immunodeficiency virus is a key challenge for global health. Vitamin D deficiency is common in people living with HIV infection. Antiretroviral therapy may create unique risk factors for vitamin D insufficiency, including alterations of vitamin D metabolism by ART.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of 25-Hydroxyvitamin D

Trials testing the same drug.

NCT03334136 — The Effect of Vitamin D Supplementation on Psoriasis Severity · NA · completed

Other recruiting trials for HIV-1-infection

Currently open trials in the same condition.

NCT07293559 — Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States · recruiting
NCT06919016 — A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1- · Phase 1 · active not recruiting
NCT06554717 — Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV · Phase 2 · recruiting
NCT06774872 — Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Succes · Phase 2 · recruiting
NCT06890988 — Ending the Epidemic Interventions in the Dental Setting - UH3 · NA · recruiting

Other University of the Punjab trials

Trials by the same sponsor.

NCT07516080 — Feasibility Trial of a Correctional Management for Juvenile Offenders · NA · recruiting
NCT07157891 — Investigating the Safety and Regenerative Potential of MSC-Derived Secretome Combined With PRGF in Knee Osteoarthritis · EARLY_PHASE1 · not yet recruiting
NCT07027930 — A Feasibility Trial of Eye Movement Desensitization and Reprocessing Therapy- Integrative Treatment Group Protocol for O · NA · recruiting
NCT07077577 — Holistic Birth Experiences: A Qualitative Exploration · NA · completed
NCT06101589 — Effect of Vitamin D Supplementation on Allostatic Load and Chronic Stress Along Line of Control in Azad Jammu Kashmir · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05306704 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of the Punjab
Last refreshed: 11 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05306704.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing